Literature DB >> 400276

Hyposensitisation in the management of recurring vaginal candidiasis.

N Rosedale, K Browne.   

Abstract

Hyposensitisation with a commercially available antigen has been attempted in the treatment of women suffering from recurring monilial vaginitis. Ten women entered the trial, each being used as her own control. Eight of them showed undoubted improvement and the average interval between relapses increased from 5.1 to 15.7 months (p. less than .01). Reasons are given for believing that allergic reactions play a part in recurrent vaginal thrush.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 400276

Source DB:  PubMed          Journal:  Ann Allergy        ISSN: 0003-4738


  10 in total

1.  Management of recurrent vulvovaginal candidiasis: unresolved issues.

Authors:  Jack D Sobel
Journal:  Curr Infect Dis Rep       Date:  2006-11       Impact factor: 3.725

2.  Vulvovaginal Candidosis (excluding chronic mucocutaneous candidosis). Guideline of the German Society of Gynecology and Obstetrics (AWMF Registry No. 015/072, S2k Level, December 2013).

Authors:  W Mendling; K Friese; I Mylonas; E-R Weissenbacher; J Brasch; M Schaller; P Mayser; I Effendy; G Ginter-Hanselmayer; H Hof; O Cornely; M Ruhnke
Journal:  Geburtshilfe Frauenheilkd       Date:  2015-04       Impact factor: 2.915

3.  Finger nails as a reservoir for Candida albicans in recurrence of vaginal candidosis.

Authors:  V C Riley; F C Odds; P E Fisk; C E Webster
Journal:  Genitourin Med       Date:  1986-10

4.  Pathogenesis of Recurrent Vulvovaginal Candidiasis.

Authors:  Jack D. Sobel
Journal:  Curr Infect Dis Rep       Date:  2002-12       Impact factor: 3.725

5.  Increased diversity of fungal flora in the vagina of patients with recurrent vaginal candidiasis and allergic rhinitis.

Authors:  Renyong Guo; Nengneng Zheng; Haifeng Lu; Hongfang Yin; Jinmei Yao; Yu Chen
Journal:  Microb Ecol       Date:  2012-07-06       Impact factor: 4.552

Review 6.  Immunopathogenesis of recurrent vulvovaginal candidiasis.

Authors:  P L Fidel; J D Sobel
Journal:  Clin Microbiol Rev       Date:  1996-07       Impact factor: 26.132

7.  Zafirlukast for severe recurrent vulvovaginal candidiasis: an open label pilot study.

Authors:  D J White; A Vanthuyne; P M Wood; J G Ayres
Journal:  Sex Transm Infect       Date:  2004-06       Impact factor: 3.519

Review 8.  Evaluation and management of vaginitis.

Authors:  P L Carr; D Felsenstein; R H Friedman
Journal:  J Gen Intern Med       Date:  1998-05       Impact factor: 5.128

Review 9.  Management of patients with recurrent vulvovaginal candidiasis.

Authors:  Jack D Sobel
Journal:  Drugs       Date:  2003       Impact factor: 9.546

10.  Chronic vulvovaginal Candida hypersensitivity: An underrecognized and undertreated disorder by allergists.

Authors:  Jonathan A Bernstein; Luqman Seidu
Journal:  Allergy Rhinol (Providence)       Date:  2015-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.